Collegium Pharmaceutical Inc. (COLL)

Business: Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management.

IPO Date: 07-May-2015

Co-Founder & Chairman: Mr. Michael Thomas Heffernan B.S. Pharm, R.Ph.

Pres, CEO & Director: Mr. Joseph J. Ciaffoni

Listing: NASDAQ: COLL

Country: United States

Headquarters: Stoughton, MA

Website: https://www.collegiumpharma.com

Market cap: $574.15 Mln

Revenue (TTM): $272.90 Mln

Earnings (TTM): $42.79 Mln

Cash: $106.70 Mln

Total Debt: $777.67 Mln

Insider's Holding: 1.39%

Liquidity: Low

52 Week range: $14.04 - 25.66

Shares outstanding: 33,973,300

9 Years Aggregate:

• CFO: $196.56 Mln
• EBITDA: $62.95 Mln
• Net Profit: $-193.99 Mln